1. Home
  2. Pharma & Healthcare
  3. Global Cannabinoid-based Antitumor Drug Market Status and Forecast 2021-2027

Global Cannabinoid-based Antitumor Drug Market Status and Forecast 2021-2027

Publication Month: Sep 2021 | No. of Pages: 139 Published By: GRD Survey
Single User License: US $ 2980
Corporate User License: US $ 5960

This report provides a comprehensive analysis of current global Cannabinoid-based Antitumor Drug market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Cannabinoid-based Antitumor Drug industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to this survey, the global Cannabinoid-based Antitumor Drug market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million by 2027.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Cannabinoid-based Antitumor Drug Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Cannabinoid-based Antitumor Drug market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Cannabinoid-based Antitumor Drug Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Cannabinoid-based Antitumor Drug industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions


Segmented by Type
Chewing Medicine
Lozenge

Segmented by Application
Clinics
Hospitals
Others

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Medicanja Ltd
Jay Pharma
GW Pharmaceuticals
Cannabics Inc.


Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Cannabinoid-based Antitumor Drug Market Status and Forecast (2016-2027)
1.3.2 Global Cannabinoid-based Antitumor Drug Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Cannabinoid-based Antitumor Drug Supply by Company
2.1 Global Cannabinoid-based Antitumor Drug Sales Volume by Company
2.2 Global Cannabinoid-based Antitumor Drug Sales Value by Company
2.3 Global Cannabinoid-based Antitumor Drug Price by Company
2.4 Cannabinoid-based Antitumor Drug Production Location and Sales Area of Main Manufacturers
2.5 Trend of Concentration Rate
3 Global and Regional Cannabinoid-based Antitumor Drug Market Status by Type
3.1 Cannabinoid-based Antitumor Drug Type Introduction
3.1.1 Chewing Medicine
3.1.2 Lozenge
3.1.3 Other
3.2 Global Cannabinoid-based Antitumor Drug Market by Type
3.2.1 Global Cannabinoid-based Antitumor Drug Sales Volume by Type (2016-2021)
3.2.2 Global Cannabinoid-based Antitumor Drug Sales Value by Type (2016-2021)
3.2.3 Global Cannabinoid-based Antitumor Drug Price by Type (2016-2021)
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Cannabinoid-based Antitumor Drug Market Status by Application
4.1 Cannabinoid-based Antitumor Drug Segment by Application
4.1.1 Clinics
4.1.2 Hospitals
4.1.3 Others
4.2 Global Cannabinoid-based Antitumor Drug Market by Application
4.2.1 Global Cannabinoid-based Antitumor Drug Sales Volume by Application (2016-2021)
4.2.2 Global Cannabinoid-based Antitumor Drug Sales Value by Application (2016-2021)
4.2.3 Global Cannabinoid-based Antitumor Drug Price by Application (2016-2021)
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Cannabinoid-based Antitumor Drug Market Status by Region
5.1 Global Cannabinoid-based Antitumor Drug Market by Region
5.1.1 Global Cannabinoid-based Antitumor Drug Sales Volume by Region
5.1.2 Global Cannabinoid-based Antitumor Drug Sales Value by Region
5.2 North America Cannabinoid-based Antitumor Drug Market Status
5.3 Europe Cannabinoid-based Antitumor Drug Market Status
5.4 Asia Pacific Cannabinoid-based Antitumor Drug Market Status
5.5 Central & South America Cannabinoid-based Antitumor Drug Market Status
5.6 Middle East & Africa Cannabinoid-based Antitumor Drug Market Status
6 North America Cannabinoid-based Antitumor Drug Market Status
6.1 North America Cannabinoid-based Antitumor Drug Market by Country
6.1.1 North America Cannabinoid-based Antitumor Drug Sales Volume by Country (2016-2021)
6.1.2 North America Cannabinoid-based Antitumor Drug Sales Value by Country (2016-2021)
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Cannabinoid-based Antitumor Drug Market Status
7.1 Europe Cannabinoid-based Antitumor Drug Market by Country
7.1.1 Europe Cannabinoid-based Antitumor Drug Sales Volume by Country (2016-2021)
7.1.2 Europe Cannabinoid-based Antitumor Drug Sales Value by Country (2016-2021)
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Cannabinoid-based Antitumor Drug Market Status
8.1 Asia Pacific Cannabinoid-based Antitumor Drug Market by Country
8.1.1 Asia Pacific Cannabinoid-based Antitumor Drug Sales Volume by Country (2016-2021)
8.1.2 Asia Pacific Cannabinoid-based Antitumor Drug Sales Value by Country (2016-2021)
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Cannabinoid-based Antitumor Drug Market Status
9.1 Central & South America Cannabinoid-based Antitumor Drug Market by Country
9.1.1 Central & South America Cannabinoid-based Antitumor Drug Sales Volume by Country (2016-2021)
9.1.2 Central & South America Cannabinoid-based Antitumor Drug Sales Value by Country (2016-2021)
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Cannabinoid-based Antitumor Drug Market Status
10.1 Middle East & Africa Cannabinoid-based Antitumor Drug Market by Country
10.1.1 Middle East & Africa Cannabinoid-based Antitumor Drug Sales Volume by Country (2016-2021)
10.1.2 Middle East & Africa Cannabinoid-based Antitumor Drug Sales Value by Country (2016-2021)
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
11.1 Supply Chain Analysis
11.2 Production Process Chart Analysis
11.3 Raw Materials and Key Suppliers Analysis
11.3.1 Raw Materials Introduction
11.3.2 Raw Materials Key Suppliers List
11.4 Cannabinoid-based Antitumor Drug Manufacturing Cost Analysis
11.5 Cannabinoid-based Antitumor Drug Sales Channel and Distributors Analysis
11.5.1 Cannabinoid-based Antitumor Drug Sales Channel
11.5.2 Cannabinoid-based Antitumor Drug Distributors
11.6 Cannabinoid-based Antitumor Drug Downstream Major Buyers
12 Global Cannabinoid-based Antitumor Drug Market Forecast by Type and by Application
12.1 Global Cannabinoid-based Antitumor Drug Sales Volume and Sales Value Forecast (2022-2027)
12.2 Global Cannabinoid-based Antitumor Drug Forecast by Type
12.2.1 Global Cannabinoid-based Antitumor Drug Sales Volume Forecast by Type
12.2.2 Global Cannabinoid-based Antitumor Drug Sales Value Forecast by Type
12.2.3 Global Cannabinoid-based Antitumor Drug Price Forecast by Type
12.3 Global Cannabinoid-based Antitumor Drug Forecast by Application
12.3.1 Global Cannabinoid-based Antitumor Drug Sales Volume Forecast by Application
12.3.2 Global Cannabinoid-based Antitumor Drug Sales Value Forecast by Application
12.3.3 Global Cannabinoid-based Antitumor Drug Price Forecast by Application
13 Global Cannabinoid-based Antitumor Drug Market Forecast by Region/Country
13.1 Global Cannabinoid-based Antitumor Drug Market Forecast by Region (2022-2027)
13.1.1 Global Cannabinoid-based Antitumor Drug Sales Volume Forecast by Region (2022-2027)
13.1.2 Global Cannabinoid-based Antitumor Drug Sales Value Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Valeant Pharmaceuticals
14.1.1 Company Information
14.1.2 Cannabinoid-based Antitumor Drug Product Introduction
14.1.3 Valeant Pharmaceuticals Cannabinoid-based Antitumor Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.1.4 SWOT Analysis
14.2 Tikun Olam
14.2.1 Company Information
14.2.2 Cannabinoid-based Antitumor Drug Product Introduction
14.2.3 Tikun Olam Cannabinoid-based Antitumor Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.2.4 SWOT Analysis
14.3 Medicanja Ltd
14.3.1 Company Information
14.3.2 Cannabinoid-based Antitumor Drug Product Introduction
14.3.3 Medicanja Ltd Cannabinoid-based Antitumor Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.3.4 SWOT Analysis
14.4 Jay Pharma
14.4.1 Company Information
14.4.2 Cannabinoid-based Antitumor Drug Product Introduction
14.4.3 Jay Pharma Cannabinoid-based Antitumor Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.4.4 SWOT Analysis
14.5 GW Pharmaceuticals
14.5.1 Company Information
14.5.2 Cannabinoid-based Antitumor Drug Product Introduction
14.5.3 GW Pharmaceuticals Cannabinoid-based Antitumor Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.5.4 SWOT Analysis
14.6 Cannabics Inc.
14.6.1 Company Information
14.6.2 Cannabinoid-based Antitumor Drug Product Introduction
14.6.3 Cannabics Inc. Cannabinoid-based Antitumor Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.6.4 SWOT Analysis
...
15 Conclusion
16 Methodology

Tables and Figures

List of Tables

Table Global Cannabinoid-based Antitumor Drug Sales Value and CAGR by Region (2016-2027)
Table Global Cannabinoid-based Antitumor Drug Sales Volume by Company (2019-2021)
Table Global Cannabinoid-based Antitumor Drug Sales Volume Market Share by Company (2019-2021)
Table Global Cannabinoid-based Antitumor Drug Sales Value by Company (2019-2021)
Table Global Cannabinoid-based Antitumor Drug Sales Value and CAGR by Region (2016-2027)
Table Global Cannabinoid-based Antitumor Drug Price by Company (2019-2021)
Table Main Manufacturers Cannabinoid-based Antitumor Drug Product Location and Sales Area
Table Global Cannabinoid-based Antitumor Drug Sales Value by Company (2019-2021)
Table Global Cannabinoid-based Antitumor Drug Sales Volume by Type (2016-2021)
Table Global Cannabinoid-based Antitumor Drug Sales Volume Market Share by Type (2016-2021)
Table Global Cannabinoid-based Antitumor Drug Sales Value by Type (2016-2021)
Table Global Cannabinoid-based Antitumor Drug Sals Value Market Share by Type (2016-2021)
Table Global Cannabinoid-based Antitumor Drug Price by Type (2016-2021)
Table North America Cannabinoid-based Antitumor Drug Sales Volume by Type (2016-2021)
Table Global Cannabinoid-based Antitumor Drug Sales Value by Type (2016-2021)
Table Europe Cannabinoid-based Antitumor Drug Sales Volume by Type (2016-2021)
Table Europe Cannabinoid-based Antitumor Drug Sales Volume Market Share by Type (2016-2021)
Table Asia Pacific Cannabinoid-based Antitumor Drug Sales Volume by Type (2016-2021)
Table Asia Pacific Cannabinoid-based Antitumor Drug Sales Volume Market Share by Type (2016-2021)
Table Central & South America Cannabinoid-based Antitumor Drug Sales Volume by Type (2016-2021)
Table Central & South America Pacific Cannabinoid-based Antitumor Drug Sales Volume Market Share by Type (2016-2021)
Table Middle East & Africa Cannabinoid-based Antitumor Drug Sales Volume by Type (2016-2021)
Table Middle East & Africa Cannabinoid-based Antitumor Drug Sales Volume Market Share by Type (2016-2021)
Table Global Cannabinoid-based Antitumor Drug Sales Volume by Application (2016-2021)
Table Global Cannabinoid-based Antitumor Drug Sales Volume Market Share by Application (2016-2021)
Table Global Cannabinoid-based Antitumor Drug Sales Value by Application (2016-2021)
Table Global Cannabinoid-based Antitumor Drug Value Market Share by Application (2016-2021)
Table Global Cannabinoid-based Antitumor Drug Price by Application (2016-2021)
Table North America Cannabinoid-based Antitumor Drug Sales Volume by Application (2016-2021)
Table Global Cannabinoid-based Antitumor Drug Sales Value by Application (2016-2021)
Table Europe Cannabinoid-based Antitumor Drug Sales Volume by Application (2016-2021)
Table Europe Cannabinoid-based Antitumor Drug Sales Volume Market Share by Application (2016-2021)
Table Asia Pacific Cannabinoid-based Antitumor Drug Sales Volume by Application (2016-2021)
Table Asia Pacific Cannabinoid-based Antitumor Drug Sales Volume Market Share by Application (2016-2021)
Table Central & South America Cannabinoid-based Antitumor Drug Sales Volume by Application (2016-2021)
Table Central & South America Pacific Cannabinoid-based Antitumor Drug Sales Volume Market Share by Application (2016-2021)
Table Middle East & Africa Cannabinoid-based Antitumor Drug Sales Volume by Application (2016-2021)
Table Middle East & Africa Cannabinoid-based Antitumor Drug Sales Volume Market Share by Application (2016-2021)
Table Global Cannabinoid-based Antitumor Drug Sales Volume by Region (2016-2021)
Table Global Cannabinoid-based Antitumor Drug Sales Volume Market Share by Region (2016-2021)
Table Global Cannabinoid-based Antitumor Drug Sales Value by Region (2016-2021)
Table Global Cannabinoid-based Antitumor Drug Value Market Share by Region (2016-2021)
Table North America Cannabinoid-based Antitumor Drug Sales Volume by Country (2016-2021)
Table North America Cannabinoid-based Antitumor Drug Sales Volume Market Share by Country (2016-2021)
Table Global Cannabinoid-based Antitumor Drug Sales Value by Region/Country (2016-2021)
Table North America Cannabinoid-based Antitumor Drug Value Market Share by Country (2016-2021)
Table Europe Cannabinoid-based Antitumor Drug Sales Volume by Country (2016-2021)
Table Europe Cannabinoid-based Antitumor Drug Sales Volume Market Share by Country (2016-2021)
Table Europe Cannabinoid-based Antitumor Drug Sales Value by Country (2016-2021)
Table Europe Cannabinoid-based Antitumor Drug Value Market Share by Country (2016-2021)
Table Asia Pacific Cannabinoid-based Antitumor Drug Sales Volume by Country (2016-2021)
Table Asia Pacific Cannabinoid-based Antitumor Drug Sales Volume Market Share by Country (2016-2021)
Table Asia Pacific Cannabinoid-based Antitumor Drug Sales Value by Country (2016-2021)
Table Asia Pacific Cannabinoid-based Antitumor Drug Value Market Share by Country (2016-2021)
Table Central & South America Cannabinoid-based Antitumor Drug Sales Volume by Country (2016-2021)
Table Central & South America Cannabinoid-based Antitumor Drug Sales Volume Market Share by Country (2016-2021)
Table Central & South America Cannabinoid-based Antitumor Drug Sales Value by Country (2016-2021)
Table Central & South America Cannabinoid-based Antitumor Drug Value Market Share by Country (2016-2021)
Table Middle East & Africa Cannabinoid-based Antitumor Drug Sales Volume by Country (2016-2021)
Table Middle East & Africa Cannabinoid-based Antitumor Drug Sales Volume Market Share by Country (2016-2021)
Table Middle East & Africa Cannabinoid-based Antitumor Drug Sales Value by Country (2016-2021)
Table Middle East & Africa Cannabinoid-based Antitumor Drug Value Market Share by Country (2016-2021)
Table Cannabinoid-based Antitumor Drug Raw Materials Key Suppliers List
Table Cannabinoid-based Antitumor Drug Distributors List
Table Cannabinoid-based Antitumor Drug Buyers List
Table Global Cannabinoid-based Antitumor Drug Sales Volume Forecast by Type (2022-2027)
Table Global Cannabinoid-based Antitumor Drug Sales Volume Market Share Forecast by Type (2022-2027)
Table Global Cannabinoid-based Antitumor Drug Value Forecast by Type (2022-2027)
Table Global Cannabinoid-based Antitumor Drug Value Market Share Forecast by Type (2022-2027)
Table Global Cannabinoid-based Antitumor Drug Price Forecast by Type (2022-2027)
Table Global Cannabinoid-based Antitumor Drug Sales Volume Forecast by Application (2022-2027)
Table Global Cannabinoid-based Antitumor Drug Value Forecast by Type (2022-2027)
Table Global Cannabinoid-based Antitumor Drug Value Forecast by Application (2022-2027)
Table Global Cannabinoid-based Antitumor Drug Value Market Share Forecast by Application (2022-2027)
Table Global Cannabinoid-based Antitumor Drug Price Forecast by Application (2022-2027)
Table Global Cannabinoid-based Antitumor Drug Sales Volume Forecast by Region (2022-2027)
Table Global Cannabinoid-based Antitumor Drug Value Forecast by Application (2022-2027)
Table Global Cannabinoid-based Antitumor Drug Value Forecast by Region (2022-2027)
Table Global Cannabinoid-based Antitumor Drug Value Market Share Forecast by Region (2022-2027)
Table Valeant Pharmaceuticals Company Information
Table Valeant Pharmaceuticals Product Introduction
Table Global Cannabinoid-based Antitumor Drug Value Forecast by Region (2022-2027)
Table Tikun Olam Company Information
Table Tikun Olam Product Introduction
Table Tikun Olam Cannabinoid-based Antitumor Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Medicanja Ltd Company Information
Table Medicanja Ltd Product Introduction
Table Medicanja Ltd Cannabinoid-based Antitumor Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Jay Pharma Company Information
Table Jay Pharma Product Introduction
Table Jay Pharma Cannabinoid-based Antitumor Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table GW Pharmaceuticals Company Information
Table GW Pharmaceuticals Product Introduction
Table GW Pharmaceuticals Cannabinoid-based Antitumor Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Cannabics Inc. Company Information
Table Cannabics Inc. Product Introduction
Table Cannabics Inc. Cannabinoid-based Antitumor Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets